Hologic To Present at the Merrill Lynch Global Pharmaceutical Conference
PRNewswire

BEDFORD, Mass., Sept. 16, 2008 /PRNewswire-FirstCall/ Hologic, Inc. (NASDAQ: HOLX) today announced that Jack Cumming, Chairman & CEO, will be presenting at the Merrill Lynch Global Pharmaceutical Conference being held September 16 - 18, 2008, at the Merrill Lynch Financial Centre in London.

Interested parties are invited to listen to a live audio webcast of Hologic's investor presentation on Tuesday, September 16, 2008, at 11:55 AM., EDT on the investor section of the Company's website at www.hologic.com/investor. An archive of the presentation will be available for replay following the conference.

About Hologic, Inc.

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic leads the industry in digital mammography systems and offers the most advanced technology for breast imaging and breast biopsy. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, osteoporosis assessment, preterm birth risk assessment, and mini C-arm for extremity imaging. For more information visit www.hologic.com.


Contact:
Deborah R. Gordon
Vice President, Investor Relations
Hologic, Inc.
Tel: 781.999.7716


Frances Doria
Director, Investor Relations
Hologic, Inc.
Tel: 781.999.7377

 

SOURCE: Hologic, Inc.